[1] LIANG Y, CHEN J, ZHENG X,et al.Ultrasound-mediated kallidinogenase-loaded microbubble targeted therapy for acute cerebral infarction[J].J Stroke Cerebrovasc Dis,2018,27(3):686-696. [2] KUSHLINSKⅡ N E, GERSHTEIN E S, NIKOLAEV A A, et al. Insulin-like growth factors (IGF), IGF-binding proteins (IGFBP), and vascular endothelial growth factor (VEGF) in blood serum of patients with colorectal cancer[J]. Bull Exp Biol Med, 2014, 156(5):684-688. [3] BAKOPOULOU A, KRITIS A, ANDREADIS D, et al. Angiogenic potential and secretome of human apical papilla mesenchymal stem cells in various stress microenvironments[J]. Stem Cells Dev, 2015, 24(21):2496-2512. [4] LONGA E Z, WEINSTEIN P, CARLSON S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1):84-91. [5] WANG W, WU B Q, CHEN G B,et al.Meta-analysis of the association of IGFBP3 and IGF1 polymorphisms with susceptibility to colorectal cancer[J].Neoplasma, 2018,65(6):855-864. [6] DENG M Y, LUO K Y, HOU T Y, et al. IGFBP3 deposited in the human umbilical cord mesenchymal stem cell-secreted extracellular matrix promotes bone formation[J]. J Cell Physiol, 2018, 233(8):5792-5804. [7] CHAN Y X, ALFONSO H, PAUL CHUBB S A,et al.Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1[J].Clin Endocrinol (Oxf), 2018,88(2):333-340. [8] 张冬梅,张文芳,鲁建华,等.大鼠视网膜缺血再灌注后IGF-1及IGFBP-3的表达和意义[J].国际眼科杂志,2012,12(3):413-415. [9] PLEŞERU A M, MIHAILĂ R G. The role of thrombin in central nervous system activity and stroke[J]. Clujul Med, 2018, 91(4):368-371. [10] WU H, GUO P, LI X,et al.Hydroxybutyrate promotes the recovery from cerebral infarction by activating Amp-activated protein kinase signaling[J].Exp Ther Med,2018,16(2):1195-1202. [11] LEE H J, LEE J S, HWANG S J,et al.Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin β4 expression[J]. Oncotarget, 2015, 6(17):15150-15163. [12] MIWA T, KOKURYO T, YOKOYAMA Y, et al. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer[J]. Cancer Med, 2015, 4(7):1091-1100. [13] SUZUKI S, MORIMOTO S, FUJISHIRO M, et al. Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis[J]. Autoimmunity, 2015, 48(4):251-258. [14] ANGUIANO-HERNANDEZ Y M, CONTRERAS-MENDEZ L, DE LOS ANGELES HERNANDEZ-CUETO M, et al. Modification of HIF-1α, NF-κB, IGFBP-3, VEGF and adiponectin in diabetic foot ulcers treated with hyperbaric oxygen[J]. Undersea Hyperb Med, 2019, 46(1):35-44. [15] HEGDE P S, WALLIN J J, MANCAO C. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics[J]. Semin Cancer Biol, 2018, 52(Pt 2):117-124. [16] KIM T K, PARK C S, JANG J, et al. Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a[J]. Mol Oncol, 2018, 12(3):356-372. [17] MELINCOVICI C S, BOŞCA A B, ŞUŞMAN S,et al.Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis[J].Rom J Morphol Embryol,2018,59(2):455-467. [18] HU W H, WANG H Y, KONG X P,et al.Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling[J].FASEB J,2019,33(1):532-544. [19] JIANG Y D, ZHANG Q H, STEINLE J J. Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina[J]. Growth Factors, 2015, 33(3):192-199. [20] 戚红霞, 李晓虹, 胡海强. 血清IGF-1、IGFBP-3、VEGF及多项白介素在结直肠癌转移监测中的意义[J]. 海南医学院学报, 2013, 19(2):176-179. [21] KARLIKOVA M, TOPOLCAN O, NARSANSKA A, et al. Circulating growth and angiogenic factors and lymph node status in early-stage breast cancer-a pilot study[J]. Anticancer Res, 2016, 36(8):4209-4214. [22] 芦小单,方艳秋,纪艳,等.可逆抑制血管内皮生长因子(VEGF)表达转基因小鼠子宫基因转录谱分析[J].生殖与避孕,2015,35(7):446-451. |